CN104531573B - A kind of bacillus amyloliquefaciens and its application - Google Patents

A kind of bacillus amyloliquefaciens and its application Download PDF

Info

Publication number
CN104531573B
CN104531573B CN201410779977.8A CN201410779977A CN104531573B CN 104531573 B CN104531573 B CN 104531573B CN 201410779977 A CN201410779977 A CN 201410779977A CN 104531573 B CN104531573 B CN 104531573B
Authority
CN
China
Prior art keywords
naringinase
liquid
bacillus amyloliquefaciens
culture
naringin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410779977.8A
Other languages
Chinese (zh)
Other versions
CN104531573A (en
Inventor
李秀婷
朱运平
伍少明
郗梦露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Technology and Business University
Original Assignee
Beijing Technology and Business University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Technology and Business University filed Critical Beijing Technology and Business University
Priority to CN201410779977.8A priority Critical patent/CN104531573B/en
Publication of CN104531573A publication Critical patent/CN104531573A/en
Application granted granted Critical
Publication of CN104531573B publication Critical patent/CN104531573B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2445Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0104Alpha-L-rhamnosidase (3.2.1.40)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention relates to a kind of bacillus amyloliquefaciens and its application, belong to technical field of microbial fermentation.The invention provides a kind of new bacterial strain;A kind of bacillus amyloliquefaciens, its preserving number are CGMCCNo.9928, and preservation date is on November 4th, 2014, and depositary institution is China Committee for Culture Collection of Microorganisms's common micro-organisms center(CGMCC).The preserving number of the present invention can produce naringinase for the bacillus amyloliquefaciens of CGMCCNo.9928.Separation and Culture first of the invention has gone out to produce the solution amylase bacillus cereuss of naringinase;In its liquid fermentation liquid, naringin enzyme activity can be up to 201.12 U/mL.

Description

A kind of bacillus amyloliquefaciens and its application
Technical field
The present invention relates to a kind of bacillus amyloliquefaciens and its application, belong to technical field of microbial fermentation.
Technical background
Naringinase is a kind of important enzyme for bitter substance hydrolysis in fruit juice, is by alpha-L-Rhamnosidase(α-L- Rhamnosidase, EC 3.2.1.40)With β-D-Glucose glycosides enzyme(β-D-glucosidase, EC3.2.1.21)The one of composition The compound enzyme system of glycoside hydrolysis is planted, while the activity with alpha-L-Rhamnosidase and β-D-Glucose glycosides two kinds of enzymes of enzyme, naringinase The naringin of bitterness can be acted on and generation Flavonoid substances are hydrolyzed, process is naringin first in alpha-L-rhamnoside Rhamnose and Pu Luning are generated under enzyme effect(Prunin, and translations prunin), three points of the bitterness about naringin of Pu Luning One of, therefore bitterness mitigated, then general Shandong would rather be broken down into the Fructus Citri grandiss without bitterness in the presence of β-D-Glucose glycosides enzyme Skin flavonoid substance(Predominantly naringin).The microbe-derived aspect of naringinase is concentrated mainly on mycete(Aspergillus niger and penicillium sp Deng), antibacterial produce naringinase relevant report it is less.
China is Orange Producing big country, but the depth that the current processing industry subject matter in orange juice is exactly peel adds Work Utilizing question.Contain abundant flavonoid of the peel of pomelo (predominantly Pericarpium Citri grandiss in the peel of Citrus reticulata Blanco for being taken as rubbish to process in a large number to drop to Glycosides), pectin, dietary fiber etc., if being made full use of, ambient pressure can not only be mitigated, can also be brought benefit to the mankind. Modern pharmacology research finds that flavonoid of the peel of pomelo has various physiologically actives:The fragility and permeability of scalable blood capillary, protection Heart, has the effects such as antiulcer, removing toxic substances, diuresis, antibacterial, antiinflammatory heat clearing away, is also a kind of efficient Natural antioxidant, is one Plant natural health promoting product.Therefore the deep processing of Pericarpium Citri grandiss will greatly improve the income of orchard worker, improve added value of Fructus Citri grandiss etc..
Although the research to naringinase is more and more deep, the production of only minority naringinase at present realizes industrialization, The heavy industrialization application aspect for limiting naringinase at present has two:First subject matter is that China's shortage is adapted to The high bacterium producing multi enzyme preparation of industrialized production, this just strongly limit application, the cultivation where the shoe pinches of high naringinase-producing strain be as Where select outstanding mutant efficient in substantial amounts of mutagenic progeny, up to the present there is no preferable method, bacterial strain Breeding Progress is slow, develops that new efficient screening technique is necessary, therefore is current working as to the cultivation of superior strain Business is anxious.Second Problem is that naringin fixation techniques for enzyme also has many defects at home, used in immobilization Reagent or carrier has high expensive, immobilization efficiency low, less stable, continuous operation are used equipment it is more complicated Deng this is accomplished by our countries and further develops easier while more applicable process for fixation, and naringinase is applied to mandarin orange And the de- bitter and existing relevant report of processing foreign of other products, but aborning should not on a large scale in China's naringinase With main cause is that the country there is no commodity naringinase prepared by scale to sell, and we should strengthen with regard to breeding high-yield naringin from now on The method of enzyme bacterial strain, and the pure enzyme of naringinase of low cost is prepared, with important practical significance.
With mycete(Aspergillus niger and penicillium sp etc.)Liquid fermentation produces naringinase and compares, and bacterial liquid fermenting and producing naringinase has Growth cycle is short, low production cost, easily controllable growth conditionss many advantages, such as, obtained researcher in recent years and more paid close attention to. But, the naringin enzymatic activity of antibacterial production is compared with mycete, also with a certain distance;Current institute reporter bacterium enzymatic production water It is flat to be less than 1000 U units per ml fermentation liquids;Bacterial fermentation produces naringinase optimum temperature partial neutral environment and may limit Its certain applications in sour environment.
Prior art(Before the present invention)The bacillus amyloliquefaciens reported are in the Biological control side of plant pathogenic fungi Face applies more, but has no that bacillus amyloliquefaciens produce the report of naringinase.
The content of the invention
The present invention has turned out a kind of bacillus amyloliquefaciens that can produce naringinase by creative work.The present invention Bacillus amyloliquefaciens liquid fermentation liquid in naringin enzyme activity reach 201.12 U/mL, naringinase total enzyme activity power after purification 10556U can be reached, specific enzyme activity power reaches 15609U/mg;The naringinase produced before far above the present invention, by antibacterial and mycete Enzyme activity.In addition, the liquid fermentation liquid of the bacillus amyloliquefaciens of the present invention also contains naringin and naringenin;Wherein naringenin It is Flavonoid substances, with health-care effecies such as blood pressure lowering, removing toxic substances, diuresis, antibacterials.The Fructus Citri grandiss that the bacillus amyloliquefaciens of the present invention are produced Glycosides enzyme, molecular weight be 32.5 kDa, optimum operative temperature, pH be respectively 45 DEG C, 7.5.The bacillus amyloliquefaciens of the present invention The naringinase that by antibacterial with mycete produced of the naringinase of product before the present invention is compared, and there is following special character:From Xie Dian The part zymologic property of naringinase is produced in afnyloliquefaciens 11568(Optimum pH and pH stability, optimum temperature and temperature stabilization Property)Deng research, show which has very big application prospect in the field such as fruit juice debitterizing of commercial application prospect, improving wine Local flavor, the fragrance component for improving beverage and production food additive in also function to important function, to naringinase isolate and purify and Property Quality Research provide important evidence to prepare the commercial enzyme preferably industrially applied.
Technical scheme
The invention provides a kind of new Bacillus amyloliquefaciens strain.
A kind of bacillus amyloliquefaciens(Bacillus amyloliquefacines )11568, its preserving number is CGMCCNo.9928, preservation date are on November 4th, 2014, and depositary institution is that China Committee for Culture Collection of Microorganisms is general Logical microorganism center(CGMCC).
The bacillus amyloliquefaciens 11568 of the present invention, which can produce naringinase.
Present invention also offers a kind of new application of bacillus amyloliquefaciens 11568.
Application of the bacillus amyloliquefaciens 11568 of the present invention in production naringinase.
Specifically a kind of application process is:
(1)The bacillus amyloliquefaciens 11568 of the present invention are carried out into slant culture, slant strains are obtained;
(2)Take slant strains to be inoculated in sterilized seed culture medium, the fermentation training under conditions of 40.9 DEG C, 180rpm Foster 48h, obtains liquid fermentation liquid;
(3)Centrifugation liquid fermentation liquid, takes supernatant;
(4)Supernatant through ammonium sulfate precipitation, ion-exchange chromatography, Sephacryl S-200 gel permeation chromatographies, Obtain naringinase.
Gained naringinase is the pure naringinase of electrophoresis that purification is 38.27;Total enzyme activity power can reach 10556U, compare enzyme Vigor reaches 15609U/mg.The molecular weight of the naringinase for being obtained be 32.5 kDa, optimum temperature, pH be respectively 45 DEG C, 7.5。
Above-mentioned steps(1)In, the slant medium contains following component in every 1L:MgSO4 0.5g、KH2PO4 1.5g、CaCl20.1g、(NH42SO4 1.5g、KCl 0.5g、KNO31.5g, yeast extract 2g, orange meal 15g, agar 20g, PH is 6.0,1 × 105 Pa 20 min of sterilizing.
Above-mentioned steps(2)In, the seed culture medium contains following component in every 1L:
Maltose 15.1g, tryptone 10g,(NH42HPO420g, NaCl 10g, yeast extract 5g, pH is 7.51;
Or, naringin 10g, tryptone 10g,(NH42HPO420g, NaCl 10g, yeast extract 5g, pH is 7.51;
Or, MgSO4 0.5g、 KH2PO4 1.5g、 CaCl20.1g、(NH42SO4 1.5g、 KCl 0.5g、KNO3 1.5g, yeast extract 2, orange meal 7.5g, pH is 6.0.
Above-mentioned steps(3)In, liquid fermentation liquid centrifugation Jing after supersonic wave wall breaking;Ultrasonic frequency is 25-30Hz, is surpassed The sound time is 10min, ultrasonic 2.5s, stops 2.5s;The rotating speed of centrifugation is 5000-6000rpm, and centrifugation time is 10-15min.
Above-mentioned steps(4)In, after ion-exchange chromatography, before gel permeation chromatography, use 0.01-0.5mol/L NaCl carries out eluting.
The step(4)Middle ammonium sulfate precipitation is concretely comprised the following steps:Ammonium sulfate is added in supernatant so as to quality Volumetric concentration is 0.01%-40%, is filtered to remove the precipitation of generation, then proceedes to add ammonium sulfate, to its mass-volume concentration Till for 40%-80%, it is filtrated to get and precipitates containing naringinase.Described mass-volume concentration is referred to:Contain sulfur in per mL supernatant The quality of sour ammonium(g).
The step(4)Intermediate ion displacement chromatography, refers to Q Sepharose Fast Flow ion-exchange chromatographies;Its tool Body step is:First with buffer system be 20mmol/L, the Tris-HCl buffer balance columns material of pH 8.5;After baseline balance 500 microlitres of destination protein amount of liquid is added, adsorption time is 30min;Entered with the NaCl solution of 0.01-0.5mol/L after absorption Row gradient elution, flow velocity are set to 1mL/min, detect naringin enzyme activity and protein content in often pipe eluent.Wherein, gradient The concrete operations of eluting are:Arranging elution program carries out gradient elution with the NaCl solution of 0.01-0.5mol/L, and flow velocity is set to 1mL/min, collects liquid.
The step(4)The concrete operations of middle gel permeation chromatography are:Fill in SephacrylS-200 post material;With 50mmol/LNaCl solution(7.2 phosphate buffer of 50mmol/L, pH is solvent), flow velocity 0.1mL/min, balance columns material;Balance Afterwards with same buffer eluting, flow velocity is maintained at 0.1mL/min, arranges often pipe and collects 1mL;Detection often in pipe naringin enzyme activity and Protein content.Wherein, SephacrylS-200 is the model of chromatographic column, and the chromatographic column of unavailable other models replaces.
Can be using one or more adjustable inclined surface apparatus culture medium and seed culture medium in hydrochloric acid, sulphuric acid or phosphoric acid pH。
The inoculum concentration of slant culture and fermentation culture can be obtained by prior art, be not required to pay performing creative labour. The inoculum concentration of slant culture can reach the seed liquor of inoculum concentration needed for fermentation culture, and the inoculum concentration of fermentation culture is generally 0.2%(v/V).
In the present invention, for the percentage ratio of the content of certain composition, if not otherwise specified, percentage by weight is referred both to (w/w).
Wherein, to the step in above-mentioned concrete application method(2)The liquid fermentation liquid for being obtained detected, testing result For:Naringin enzyme activity reaches 201.12 U/mL, and naringinase total enzyme activity power can reach 10556U after purification, and specific enzyme activity power reaches 15609U/mg.Also containing naringin, naringin hydrolysis substrate naringenin in the liquid fermentation liquid.Naringenin is Flavonoid substances, With health-care effecies such as blood pressure lowering, removing toxic substances, diuresis, antibacterials.
So, present invention also offers a kind of liquid fermentation liquid of bacillus amyloliquefaciens 11568.
Technical term explanation used by of the invention:
1U refers to that the naringin enzyme amount decomposed required for 1 μ g naringin substrates per minute is referred to as a naringinase enzyme activity.
Beneficial effect
Separation and Culture has gone out to produce the solution amylase bacillus cereuss 11568 of naringinase first.
In the liquid fermentation liquid of the solution amylase bacillus cereuss 11568 of the present invention, naringin enzyme activity can be up to 201.12 U/mL。
The naringinase of the present invention, compared with the naringinase before the present invention, possesses following advantage:Optimum pH and pH stable Property, the performance such as optimum temperature and temperature stability it is good, have greatly using front in the field such as fruit juice debitterizing of commercial application prospect Scape, also functions to important function, in the local flavor, the fragrance component for improving beverage and production food additive for improving wine to Fructus Citri grandiss Glycosides enzyme isolate and purify and property Quality Research provides important evidence to prepare the commercial enzyme preferably industrially applied.
The method that the present invention prepares naringinase, compared with before the present invention, antibacterial, funguses prepare the method for naringinase, has Producing enzyme level height, short fermentation time, easily controllable growth conditionss, be easily isolated, purity is high, simple to operate, mild condition etc. is all Many advantages, the application of entirely appropriate industrialized production.It is to crush the orange peel of 60 mesh as naringinase fermentation substrate, fully sharp It is with house refuse garbage, cost-effective.
Preservation explanation
China Committee for Culture Collection of Microorganisms's common micro-organisms center of depositary institution
Address Yard 1, BeiChen xi Road, Chaoyang District, Beijing City Institute of Microorganism, Academia Sinica
Preservation date:On November 4th, 2014
Deposit number:CGMCCNo.9928
Classification And Nomenclature bacillus amyloliquefaciens(Bacillus amyloliquefaciens).
Description of the drawings
The testing result of the liquid fermentation liquid that Fig. 1 is obtained by embodiment 2;
In Fig. 1,2.609 peaks represent naringin;6.582 peak is naringenin;
Fig. 2 produces naringin enzyme purification electrophoretogram by bacterial strain 11568;
In Fig. 2:M- standard protein samples;The protein band of 1- crude enzyme liquids;The protein band of 2-40 ~ 80% ammonium sulfate precipitation concentration gained; The protein band that 3- Jing Q Sepharose Fast Flow ion-exchange chromatographies are obtained;4- Jing Sephacryl S-200 gel filtrations The protein band that chromatography is obtained.
Specific embodiment
Below in described all specific embodiments, if no special instructions, method commonly used in the art is.In embodiment Unreceipted particular technique or condition person, according to technology or condition described by document in the art(With reference to the phase of Puri et al. Close document)Or carry out according to product description.Agents useful for same or the unreceipted production firm person of instrument, are and can pass through commercial The conventional products of acquisition.
1 bacillus amyloliquefaciens of embodiment, 11568 screening and separating and identification
First, bacillus amyloliquefaciens JNU002(Bacillus amyloliquefacines )11568 screening and separating
2g collections are weighed from soil sample in all parts of the country or mouldy Pericarpium Citri Reticulatae or/and Pericarpium Citri grandiss, in the 18mL equipped with sterilization treatment 30min is vibrated in the 100mL conical flasks of normal saline, a little bead is preferably put in conical flask.Then distinguish dilute with sterilized water Volumetric concentration is interpreted into for 1 × 10-3、1×10-4The diluent of two gradients, draws 100 μ L diluents with the pipette tips of sterilizing respectively Coat in the selectivity plating medium prepared in advance and sterilize, 48-96h is cultivated in 30 DEG C.From selectivity flat board culture Line on base separates single bacterium colony, and the part film-making microscopy in the single bacterium colony of picking is judged bacterial strain purity(Micro- sem observation thalline For same morphological characteristic).If not pure bacterium colony, repeated multiple times line is answered to separate single bacterium colony, till pure bacterium colony is obtained.Will The pure bacterium colony for obtaining is preserved with slant medium, obtains bacterial strain pure culture body;Meanwhile, it is mild-natured in the selection of the pure bacterium colony isolated Deca diglycol in plate culture medium(DES)Reagent, has seen whether transparent circle phenomenon, and the bacterial strain for having transparent circle is selected Out, as the basis of follow-up secondary screening.The nutritional labeling of the selectivity plating medium is(g/L):MgSO40.5, KH2PO4 1.5, CaCl2 0.1,(NH4)2SO4 1.5, KCl 0.5, KNO31.5, yeast extract 2, orange meal 7.5, agar 20.
Follow-up secondary screening:The bacterial strain for having transparent circle is carried out into shake-flask culture, the big bacterial strain of transparent circle is chosen as aimed strain, It is named as:Bacillus amyloliquefaciens 11568;The nutritional labeling of Shake flask medium used is(g/L):MgSO4 0.5, KH2PO4 1.5, CaCl2 0.1,(NH4)2SO41.5, KCl 0.5, KNO31.5, yeast extract 2, orange meal 7.5, pH are 6.0.
2nd, bacillus amyloliquefaciens(Bacillus amyloliquefacines )11568 identifications
1. morphological characteristic
In LB culture medium flat plates culture 48 hours at 40 DEG C, bacterium colony surface is smooth, moistening, and edge is irregular, gram dye Color is positive, 2 ~ 15mm of colony diameter, can spread growth, and bacterium colony is transparent, and without parasporal crystal, bacterium colony is without projection.It is flat in LB culture medium It is in rod-short that thalline is cultivated on plate.The nutritional labeling of the LB culture medium flat plates culture is(g/L):Yeast extract 5, NaCl 10, tryptone 10.
2.16S rDNA sequence analysis:
Few sequence nucleotide primer is that funguses PCR expands universal primer:
Forward primer ITS1:5'-TCCGTAGGTGAACCTGCGG-3', as shown in SEQ ID NO.2;
Downstream primer ITS4:5'-TCCTCCGCTTATTGATATGC -3';As shown in SEQ ID NO.3;
The 16S rDNA of the bacterium are expanded using PCR technologies;
The concrete operations of pcr amplification reaction are as follows(The operation not illustrated is routine operation):
Reaction system is sequentially added into PE tubules;Open PCR amplification instrument amplification;Instrument is closed after completing reaction;Take out anti- Liquid is answered to enter row agarose gel electrophoresis inspection DNA amplification
Various reagents and consumption involved by pcr amplification reaction system:Pcr amplification reaction system:0.5 μ L template DNAs, 1.0 μ L dNTP, 0.5 μ L Taq enzymes, each 1.0 μ L of primer, moisturizing to 50 μ L.
Pcr amplification reaction condition:94 DEG C of 4 min of preheating, each circulation include:94 DEG C of degeneration 30s, 56 DEG C of 30 s of annealing, 72 DEG C of extension 6min, 30 circulations, finally again with 72 DEG C, 10 min.
Pcr amplification product entrusts AudioCodes prosperous company in Beijing to complete examining order.
PCR primer is sequenced Jing after agarose gel electrophoresiies inspection, and DNA sequence table is:SEQ ID NO.1.
3. physiological and biochemical property
According to《Primary Jie Shi handbooks》(R.E. Buchanan, basic this grade of N.E. are compiled, Science Press, and 1984)Bacterial strain is entered Row Physiology and biochemistry is identified(It is shown in Table 1), its physiological and biochemical property matched with bacillus amyloliquefaciens.
Table 1:Biochemical reactions table
Preparation of the embodiment 2 containing naringinase, bacillus amyloliquefaciens 11568 liquid fermentation liquid
(1)Slant culture:Bacillus amyloliquefaciens 11568 are inoculated on slant medium, are cultivated 48 hours at 40 DEG C, Obtain inclined-plane bacterial strain.Slant medium used(g/L)For:MgSO4 0.5、KH2PO4 1.5、CaCl20.1、(NH42SO4 1.5、 KCl 0.5, KNO3 1.5, yeast extract 2, orange meal 15, agar 20, pH 6.0,1 × 105Pa 20 min of sterilizing.
(2)Liquid shake-flask fermentation:Will inclined-plane bacterial strain with 0.2%(v/V)Inoculum concentration be inoculated into liquid submerged culture base In, 40.9 DEG C of cultivation temperature, shaking speed 180r/min, incubation time 48h;Obtain liquid fermentation liquid.Liquid submerged culture base(g/ L)For:MgSO4 0.5、KH2PO4 1.5、CaCl20.1、(NH42SO4 1.5、 KCl 0.5、KNO31.5th, yeast extract 2, Fructus Citri tangerinae Corium farinosum 7.5, pH 6.0,1 × 105Pa 20 min of sterilizing.
(3)By high performance liquid chromatography(Water:Methanol=1:1)Determine the composition of liquid fermentation liquid, testing result such as Fig. 1: Contain naringin, naringenin in liquid fermentation liquid.
(4)The confirmation of naringinase and the measure of enzyme activity:Using improvement Davis methods, 1 g/ L Fructus Citri grandiss are added in test tube 2 mL of skin glycosides titer, 0. 2 mol/ L pH5.5 acetate buffer solution 1.9mL, preheats 5 min in 40 DEG C of thermostat water baths, then Add 0.1 mL liquid shake-flask fermentation liquid, 40 DEG C of 30 min of isothermal reaction;Obtain enzymolysis solution.Take 0.1 mL enzymolysis solutions and add 90% The NaOH solution 0.5mL of diglycol 5mL, 1mol/L, distilled water 0.4mL, and take 0.1 mL distilled water and do blank (Distilled water is enzyme activity Basis with the difference of enzymolysis solution absorbance).After 40 DEG C of 15 min of water bath with thermostatic control, at 420 nm Survey absorbance.So that, under the conditions of 40 DEG C, pH5.5, the enzyme amount needed for 1 μ g naringins of hydrolysis per minute is 1 enzyme activity unit (U).Measure step(2)The naringinase enzyme activity of the liquid fermentation liquid of preparation is 197.83U/mL.
Preparation of the embodiment 3 containing naringinase, bacillus amyloliquefaciens 11568 liquid fermentation liquid
By 2 step of embodiment(1)Cultured inclined-plane bacterial strain is with 0.2%(v/V)Inoculum concentration be inoculated into equipped with liquid culture In the 250ml conical flasks of base, liquid shake-flask fermentation, 40.9 DEG C of fermentation temperature, 180 r/min of shaking speed, fermentation time are carried out 48 h;Obtain liquid fermentation liquid.Liquid culture based component(g/L):Naringin 10, tryptone 10,(NH42HPO4 20、NaCl 10th, yeast extract 5;PH 7.51,1 × 105Pa 20 min of sterilizing.
(3)By high performance liquid chromatography(Water:Methanol=1:1)Determine the composition of liquid fermentation liquid, testing result such as Fig. 1: Contain naringin, naringenin in liquid fermentation liquid.
(4)Assay method according to the naringinase enzyme activity of embodiment 2 determines the liquid fermentation liquid prepared by the present embodiment Naringin enzyme activity;Testing result is:Naringin enzyme activity reaches 140 U/mL.
Preparation of the embodiment 4 containing naringinase, bacillus amyloliquefaciens 11568 liquid fermentation liquid
By 2 step of embodiment(1)Cultured inclined-plane bacterial strain is with 0.2%(v/V)Inoculum concentration be inoculated into equipped with liquid culture In the 250ml conical flasks of base, liquid shake-flask fermentation, 40.9 DEG C of fermentation temperature, 180 r/min of shaking speed, fermentation time are carried out 48 h;Obtain liquid fermentation liquid.Liquid culture based component(g/L):Maltose 15.1, tryptone 10,(NH42HPO4 20、 NaCl 10, yeast extract 5;PH 7.51,1 × 105Pa 20 min of sterilizing.
(3)By high performance liquid chromatography(Water:Methanol=1:1)Determine the composition of liquid fermentation liquid, testing result such as Fig. 1: Contain naringin, naringenin in liquid fermentation liquid.
(4)Assay method according to the naringinase enzyme activity of embodiment 2 determines the liquid fermentation liquid prepared by the present embodiment Naringin enzyme activity;Testing result is:Naringin enzyme activity reaches 201.12 U/mL, at home and abroad locates in naringinase correlational study In higher producing enzyme level.
5 bacillus amyloliquefaciens of embodiment, 11568 liquid fermentation produces naringinase
By centrifugation after liquid fermentation liquid supersonic wave wall breaking, supernatant is taken.Wherein, ultrasonic frequency is 25Hz, ultrasound Time is 10min, ultrasonic 2.5s, stops 2.5s;The rotating speed of centrifugation is 5000rpm, and centrifugation time is 10min.
By supernatant ammonium sulfate precipitation.Concrete operations are:Ammonium sulfate is added in supernatant so as to which quality volume is dense Spend for 40%, be filtered to remove the precipitation of generation, then ammonium sulfate continuously added in filtrate, to its mass-volume concentration be Till 40%-80%, it is filtrated to get and precipitates containing naringinase.Described mass-volume concentration means:Contain in per mL supernatant The quality of ammonium sulfate(g).
Naringinase precipitation 0.4mol/L NaCl will be contained(The concentration of NaCl can also be 00.1-0.5mol/L)Washed It is de-;The concrete operations of eluting are:First with buffer system be 20mmol/L, the Tris-HCl buffer balance columns of pH 8.5 Material;500 microlitres of destination protein amount of liquid is added after baseline balance, adsorption time is 30min;0.01-0.5mol/ is used after absorption The NaCl solution of L carries out gradient elution, and flow velocity is set to 1mL/min, detects naringin enzyme activity and protein in often pipe eluent Content.
After by eluting containing naringinase precipitate, carry out successively Q Sepharose Fast Flow ion-exchange chromatographies, SephacrylS-200 gel permeation chromatographies, that is, obtain naringinase.
Which concretely comprises the following steps:Fill in SephacrylS-200 post material;Use 50mmol/LNaCl solution(50mmol/L, pH 7.2 phosphate buffers are solvent), flow velocity 0.1mL/min, balance columns material;With same buffer eluting after balance, flow velocity is maintained at 0.1mL/min, arranges often pipe and collects 1mL;Detect naringin enzyme activity and protein content in often pipe;Wherein, SephacrylS- 200 is the model of chromatographic column, and the chromatographic column of unavailable other models replaces.
Respectively liquid fermentation liquid prepared by embodiment 2,3 or 4 is carried out separating, purification, obtain purification for 38.27 The pure naringinase of electrophoresis;Purity and Rate activity are shown in Table 2.
Table 2
Jing SDS-PAGE can measure the molecular weight of the enzyme and be 32.5 kDa, and SDS-PAGE results are shown in Fig. 2.
<110>Beijing Technology and Business University
<120>A kind of bacillus amyloliquefaciens and its application
<160>3
<210>1
<211>1443
<212>DNA
<213>Bacillus amyloliquefaciens(Bacillus amyloliquefaciens)11568
<400>1
CCTCTGTCAC TTCGGCGGCT GGCTCCATAA AGGTTACCTC ACCGACTTCG GGTGTTACAA 60
ACTCTCGTGG TGTGACGGGC GGTGTGTACA AGGCCCGGGA ACGTATTCAC CGCGGCATGC 120
TGATCCGCGA TTACTAGCGA TTCCAGCTTC ACGCAGTCGA GTTGCAGACT GCGATCCGAA 180
CTGAGAACAG ATTTGTGGGA TTGGCTTAAC CTCGCGGTTT CGCTGCCCTT TGTTCTGTCC 240
ATTGTAGCAC GTGTGTAGCC CAGGTCATAA GGGGCATGAT GATTTGACGT CATCCCCACC 300
TTCCTCCGGT TTGTCACCGG CAGTCACCTT AGAGTGCCCA ACTGAATGCT GGCAACTAAG 360
ATCAAGGGTT GCGCTCGTTG CGGGACTTAA CCCAACATCT CACGACACGA GCTGACGACA 420
ACCATGCACC ACCTGTCACT CTGCCCCCGA AGGGGACGTC CTATCTCTAG GATTGTCAGA 480
GGATGTCAAG ACCTGGTAAG GTTCTTCGCG TTGCTTCGAA TTAAACCACA TGCTCCACCG 540
CTTGTGCGGG CCCCCGTCAA TTCCTTTGAG TTTCAGTCTT GCGACCGTAC TCCCCAGGCG 600
GAGTGCTTAA TGCGTTAGCT GCAGCACTAA GGGGCGGAAA CCCCCTAACA CTTAGCACTC 660
ATCGTTTACG GCGTGGACTA CCAGGGTATC TAATCCTGTT CGCTCCCCAC GCTTTCGCTC 720
CTCAGCGTCA GTTACAGACC AGAGAGTCGC CTTCGCCACT GGTGTTCCTC CACATCTCTA 780
CGCATTTCAC CGCTACACGT GGAATTCCAC TCTCCTCTTC TGCACTCAAG TTCCCCAGTT 840
TCCAATGACC CTCCCCGGTT GAGCCGGGGG CTTTCACATC AGACTTAAGA AACCGCCTGC 900
GAGCCCTTTA CGCCCAATAA TTCCGGACAA CGCTTGCCAC CTACGTATTA CCGCGGCTGC 960
TGGCACGTAG TTAGCCGTGG CTTTCTGGTT AGGTACCGTC AAGGTGCCGC CCTATTTGAA 1020
CGGCACTTGT TCTTCCCTAA CAACAGAGCT TTACGATCCG AAAACCTTCA TCACTCACGC 1080
GGCGTTGCTC CGTCAGACTT TCGTCCATTG CGGAAGATTC CCTACTGCTG CCTCCCGTAG 1140
GAGTCTGGGC CGTGTCTCAG TCCCAGTGTG GCCGATCACC CTCTCAGGTC GGCTACGCAT 1200
CGTCGCCTTG GTGAGCCGTT ACCTCACCAA CTAGCTAATG CGCCGCGGGT CCATCTGTAA 1260
GTGGTAGCCG AAGCCACCTT TTATGTCTGA ACCATGCGGT TCAGACAACC ATCCGGTATT 1320
AGCCCCGGTT TCCCGGAGTT ATCCCAGTCT TACAGGCAGG TTACCCACGT GTTACTCACC 1380
CGTCCGCCGC TAACATCAGG GAGCAAGCTC CCATCTGTCC GCTCGACTTG CATGTATAGG 1440
CAC 1443
<210>2
<211>19
<212>DNA
<213>Artificial sequence
<400>2
TCCGTAGGTG AACCTGCGG 19
<210>3
<211>20
<212>DNA
<213>Artificial sequence
<400>3
TCCTCCGCTT ATTGATATGC 20

Claims (5)

1. a kind of bacillus amyloliquefaciens(Bacillus amyloliquefacines )11568, its preserving number is CGMCCNo.9928。
2. application of the bacillus amyloliquefaciens 11568 described in a kind of claim 1 in production naringinase.
3. a kind of liquid fermentation liquid, it is characterised in that its preparation method comprises the steps:
(1)Bacillus amyloliquefaciens 11568 are carried out into slant culture, slant strains are obtained;
(2)Take slant strains to be inoculated in sterilized seed culture medium, the fermentation culture under conditions of 40.9 DEG C, 180rpm 48h, obtains liquid fermentation liquid.
4. liquid fermentation liquid according to claim 3, it is characterised in that above-mentioned steps(1)In, what the slant culture was used Slant medium, contains following component in every 1L:MgSO4 0.5g、KH2PO4 1.5g、CaCl20.1g、(NH42SO4 1.5g、 KCl 0.5g、KNO31.5g, yeast extract 2g, orange meal 15g, agar 20g, pH are 6.0,1 × 105Pa 20 min of sterilizing.
5. liquid fermentation liquid according to claim 3, it is characterised in that above-mentioned steps(2)In, the seed culture medium, often Contain following component in 1L:
Maltose 15.1g, tryptone 10g,(NH42HPO420g, NaCl 10g, yeast extract 5g, pH is 7.51;
Or, naringin 10g, tryptone 10g,(NH42HPO420g, NaCl 10g, yeast extract 5g, pH is 7.51;
Or, MgSO4 0.5g、 KH2PO4 1.5g、 CaCl20.1g、(NH42SO4 1.5g、KCl 0.5g、KNO3 1.5g、 Yeast extract 2g, orange meal 7.5g, pH is 6.0.
CN201410779977.8A 2014-12-17 2014-12-17 A kind of bacillus amyloliquefaciens and its application Expired - Fee Related CN104531573B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410779977.8A CN104531573B (en) 2014-12-17 2014-12-17 A kind of bacillus amyloliquefaciens and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410779977.8A CN104531573B (en) 2014-12-17 2014-12-17 A kind of bacillus amyloliquefaciens and its application

Publications (2)

Publication Number Publication Date
CN104531573A CN104531573A (en) 2015-04-22
CN104531573B true CN104531573B (en) 2017-04-05

Family

ID=52847208

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410779977.8A Expired - Fee Related CN104531573B (en) 2014-12-17 2014-12-17 A kind of bacillus amyloliquefaciens and its application

Country Status (1)

Country Link
CN (1) CN104531573B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106520641B (en) * 2016-12-30 2020-02-07 甘肃尚农生物科技有限公司 Bacillus amyloliquefaciens and preparation method of extracellular polysaccharide thereof
CN114369558B (en) * 2022-03-22 2022-06-07 华南理工大学 Serratia marcescens and application thereof in naringinase production

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0599159A2 (en) * 1992-11-27 1994-06-01 Hoechst Aktiengesellschaft Alpha-L-rhamnosidase for obtaining rhamnose, process for the preparation and use
CN103060287A (en) * 2013-01-10 2013-04-24 集美大学 Naringinase fermentation medium
CN103789332A (en) * 2014-03-10 2014-05-14 湖北工业大学 Construction of yeast strain having naringinase producing and recycling functions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0599159A2 (en) * 1992-11-27 1994-06-01 Hoechst Aktiengesellschaft Alpha-L-rhamnosidase for obtaining rhamnose, process for the preparation and use
CN103060287A (en) * 2013-01-10 2013-04-24 集美大学 Naringinase fermentation medium
CN103789332A (en) * 2014-03-10 2014-05-14 湖北工业大学 Construction of yeast strain having naringinase producing and recycling functions

Also Published As

Publication number Publication date
CN104531573A (en) 2015-04-22

Similar Documents

Publication Publication Date Title
CN103695341B (en) A kind of algin catenase secreted by marine bacteria and preparation method thereof
CN104404016B (en) Naringinase production method
CN110527637A (en) A kind of Aspergillus terreus bacterial strain producing aconitic acid and its construction method and application
CN108018218A (en) One plant height produces ethyl acetate yeast strain and its cultural method and application
CN103667132A (en) Bacillus cereus and application thereof to improve plant drought-resistant capability
CN106434369B (en) One plant of aspergillus oryzae for producing L MALIC ACID and its application
CN107400654A (en) A kind of recombination bacillus coli of alpha-glucosidase gene containing α and its application
CN105695340B (en) Aspergillus oryzae and application thereof
CN102061278B (en) Methylovorus sp. MP688 and application thereof
CN108220169A (en) A kind of separation screening and its identification method of degraded polystyrene strain
CN104531573B (en) A kind of bacillus amyloliquefaciens and its application
CN103667072B (en) A kind of Huperzia serrata endogenetic epiphyte and the application at preparation 8 α, 15 α-epoxidation selagine thereof
CN106635872A (en) Bacillus mojavensis and application thereof
CN103224920A (en) Method for separation purification of high temperature-resistant beta-amylase from bacillus subtilis
CN103045487A (en) Bacterial strain for producing citric acid and method for fermenting and producing critic acid through fermentation of bacterial strain
CN102757914B (en) Paenibacillus xylanilyticus strain and method for preparing xyloglucanase by using same
CN106636252A (en) Thelephora ganbajun Zang exopolysaccharide, preparation method thereof and application of exopolysaccharide
CN106754486A (en) One plant height produces pseudomonad and its enzymatic production method of trehalose synthase
CN102433289B (en) Strain for producing citrulline and method for biologically synthesizing citrulline with same
CN104774794A (en) Strain capable of producing D-mannose isomerase and method for producing D-mannose isomerase by using same
CN102433290B (en) Strain for producing citrulline and method for biologically synthesizing citrulline with same
CN106085880B (en) A kind of separation method and used medium of smut
CN107418922A (en) A kind of rhizosphere bacillus and its method using tobacco industry discarded object production hexyl acetate
Udomsaksakul et al. Indigenous Saccharomyces cerevisiae strains from coconut inflorescence sap: characterization and use in coconut wine fermentation
CN107674839A (en) A kind of method of Fusarium solani and its fermenting and producing dextranase

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170405

Termination date: 20191217